TARA SCHEDULE 13G/A: SEC filing

Janus Henderson Group Ltd.

Filed with the SEC on · accession 0001274173-26-000267

TARA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).

Summary of the filing

Janus Henderson Group Ltd. filed an amended Schedule 13G indicating it beneficially owns 0% (0 shares) of Protara Therapeutics, Inc. common stock, a decrease from its prior filing.

Key details

Shares beneficially owned$0
Percent of class beneficially owned$0
Filer / former beneficial ownerJanus Henderson Group Ltd.
IssuerProtara Therapeutics, Inc.
Head of north america compliance, janus henderson group ltd.Kristin Mariani

✦ Ask GOAX AI about this filing — what it means for TARA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TARA?

Click here

Frequently asked questions

What did TARA file with the SEC on Nov 16, 2026?

TARA filed a SCHEDULE 13G/A (SEC filing). Janus Henderson Group Ltd. filed an amended Schedule 13G indicating it beneficially owns 0% (0 shares) of Protara Therapeutics, Inc. common stock, a decrease from its prior filing.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other TARA SEC filings

Get alerts when TARA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days